Search results for abx831254

Lirilumab, Abbexa, abx831254

Lirilumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting KIRD2 subgroup, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Lirilumab has been used in trials studying the treatment of Leukemia, CANCER, NOS, Multiple Myeloma, Lymphocytic Leukemia, and Acute Myeloid Leukemia, among others.